← Open Payments lookup

MICHELLE HANCOCK: Open Payments

NPI 1386355774 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,157 in 129 payments from 19 companies in 2025. Trend: 2023 $845 · 2024 $1,896 · 2025 $2,157

Food & beverage: $2,150Education: $8
CompanyPaymentsAmount
ABBVIE INC.27$401
Otsuka America Pharmaceutical, Inc.17$286
Teva Pharmaceuticals USA, Inc.11$231
MDD US Operations, LLC17$177
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$175
E.R. Squibb & Sons, L.L.C.7$166
Lundbeck LLC7$146
Vanda Pharmaceuticals Inc.6$138
Janssen Pharmaceuticals, Inc4$74
Takeda Pharmaceuticals U.S.A., Inc.4$66

Products named: VRAYLAR, REXULTI, Qelbree, CAPLYTA, COBENFY, AUSTEDO XR, FANAPT, UZEDY.

Industry payments across IA — which companies pay providers there.